Company intelligence / Profile preview

Micron Biomedical

Atlanta, Georgia, United Statesmicronbiomedical.com ↗
Ownership
Private
Employees
~20
Development stage
Phase 2
01

Overview

Micron Biomedical’s dissolvable microneedle patch technology has demonstrated at least equivalent efficacy to traditional injections in adults and children as young as nine months old. The company recently published positive Phase 1/2 data for needle-free vaccines in children and has advanced to the world’s first Phase 2 trial of this technology in infants. The platform enables painless self-administration without needles, reduces cold chain requirements, medical waste, and can be administered by non-medical personnel—addressing key barriers to global immunization access.

Therapeutic areas
Infectious Diseases
Modalities
Dissolvable microarray (microneedle) patches for drug and vaccine delivery
Industry
Biotech
02

Drug pipeline

3 assets

measles and rubella vaccine

2

2 more assets in the full pipeline.

03

Partnerships

CEPI (Coalition for Epidemic Preparedness Innovations)BARDA (Biomedical Advanced Research and Development Authority)Zipcode Bio (collaboration on mRNA flu vaccine)Bill & Melinda Gates FoundationPATHGeorgia Research Alliance

Beyond the preview

Go deeper on Micron Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Micron Biomedical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call